FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 2851259 · Received November 29, 2012

Report

Report Number
1030489-2012-02481
Event Type
Injury
Date Received
November 29, 2012
Date of Event
September 20, 2012
Report Date
October 30, 2012
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
WI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

LITERATURE ARTICLE CITATION: WANG ET AL. THIRTY-DAY READMISSIONS AFTER ELECTIVE SPINE SURGERY FOR DEGENERATIVE CONDITIONS AMONG US MEDICARE BENEFICIARIES. THE SPINE JOURNAL (2012). MEAN AGE (CERVICAL) 72.5 YRS. MEAN AGE (LUMBAR) 74.1 YRS. DATES OF IMPLANT: 2003-2007. (B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Description of Event or Problem · 1

IT WAS REPORTED IN A LITERATURE PUBLICATION THAT A RETROSPECTIVE COHORT STUDY OF 343,068 MEDICARE BENEFICIARIES WHO UNDERWENT ELECTIVE CERVICAL AND LUMBAR SPINE SURGERY FOR DEGENERATIVE CONDITIONS WAS CONDUCTED. READMISSIONS WITHIN 30 DAYS OF DISCHARGE, EXCLUDING READMISSIONS FOR REHABILITATION, WERE RECORDED: 329 PATIENTS UNDERWENT CERVICAL FUSION USING BMP; 2211 PATIENTS UNDERWENT LUMBAR FUSION USING BMP. BMP-AUGMENTED FUSIONS WERE MORE COMMON IN THE LUMBAR COHORT (23% OF FUSIONS) COMPARED WITH THE CERVICAL COHORT (6.2% OF FUSIONS). SURGICAL APPROACH ALSO DIFFERED BETWEEN THE CERVICAL AND LUMBAR SPINE PATIENTS. THE CERVICAL COHORT MOST COMMONLY UNDERWENT SURGERY FROM AN ANTERIOR APPROACH (67.0%) COMPARED WITH THE LUMBAR COHORT, WHICH MORE COMMONLY UNDERWENT SURGERY FROM THE POSTERIOR APPROACH (98.3%). THE USE OF BMP DID NOT ADD A SIGNIFICANTLY INCREASED RISK BEYOND THE NUMBER OF LEVELS FUSED; 9 PATIENTS DEVELOPED RESPIRATORY FAILURE REQUIRING READMISSION WITHIN 30 DAYS FOLLOWING A CERVICAL FUSION PROCEDURE WITH BMP.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R